Plunkett Research Online: Correvio Pharma Corp

CORREVIO PHARMA CORP (CORV:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Correvio Pharma Corp, formerly Cardiome Pharma Corp., is a drug discovery and development company focused on the development of proprietary drugs for the treatment and prevention of cardiovascular diseases. Its primary products are designed to address atrial fibrillation, the most common cardiac ar.....



Correvio Pharma Corp
Ticker: CORV
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 677-6905
Fax: 604 677-6915
Address: 1441 Creekside Drive
6th Floor
Vancouver, BC V6J 4S7 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Cardiac
ContactsDescription
William HunterCEO/Director/President
Justin RenzCFO
See More
Correvio Pharma Corp, formerly Cardiome Pharma Corp., is a drug discovery and development company focused on the development of proprietary drugs for the treatment and prevention of cardiovascular diseases. Its primary products are designed to address atrial fibrillation, the most common cardiac ar.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Cardiome Pharma Corp
BRINAVESS
AGGRASTAT
XYDALBA
ZEVTERA/MABELIO
TREVYENT
ESMOCARD
ESMOCARD LYO
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: